Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisaku Masuda

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Journal of Atherosclerosis and Thrombosis|August 30, 2021
Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) StudyRyo Naito, Hiroyuki Daida, Daisaku Masuda, et al.
Journal of Atherosclerosis and Thrombosis|January 26, 2016
Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart DiseaseShizuya Yamashita, Daisaku Masuda, Tohru Ohama, et al.
Journal of Atherosclerosis and Thrombosis|June 17, 2026
A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator PemafibrateTomoko Otsuki, Yumi Chung, Yusuke Kawachi, et al.
Journal of Lipid Research|February 9, 2012
Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patientsMiao Hu, Winnie Chiu Wing Chu, Shizuya Yamashita, et al.
Journal of Atherosclerosis and Thrombosis|August 8, 2017
A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in MiceMasami Sairyo, Takuya Kobayashi, Daisaku Masuda, et al.
Medicine|May 22, 2015
Effects of phenotypic and genotypic factors on the lipid responses to niacin in Chinese patients with dyslipidemiaMiao Hu, Ya-Ling Yang, Chi-Fai Ng, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 18, 2010
High index of microcirculatory resistance level after successful primary percutaneous coronary intervention can be improved by intracoronary administration of nicorandilNoritoshi Ito, Shinsuke Nanto, Yasuji Doi, et al.
Journal of Molecular and Cellular Cardiology|December 24, 2019
Progranulin deficiency leads to enhanced age-related cardiac hypertrophy through complement C1q-induced β-catenin activationYinghong Zhu, Tohru Ohama, Ryota Kawase, et al.
Journal of Atherosclerosis and Thrombosis|March 22, 2017
Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting StateTakashi Miida, Kunihiro Nishimura, Satoshi Hirayama, et al.
Journal of Atherosclerosis and Thrombosis|October 8, 2020
Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density LipoproteinTakeshi Okada, Mizuki Sumida, Tohru Ohama, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Journal of Atherosclerosis and Thrombosis|August 30, 2021
Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) StudyRyo Naito, Hiroyuki Daida, Daisaku Masuda, et al.
Journal of Atherosclerosis and Thrombosis|January 26, 2016
Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart DiseaseShizuya Yamashita, Daisaku Masuda, Tohru Ohama, et al.
Journal of Atherosclerosis and Thrombosis|June 17, 2026
A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator PemafibrateTomoko Otsuki, Yumi Chung, Yusuke Kawachi, et al.
Journal of Lipid Research|February 9, 2012
Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patientsMiao Hu, Winnie Chiu Wing Chu, Shizuya Yamashita, et al.
Journal of Atherosclerosis and Thrombosis|August 8, 2017
A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in MiceMasami Sairyo, Takuya Kobayashi, Daisaku Masuda, et al.
Medicine|May 22, 2015
Effects of phenotypic and genotypic factors on the lipid responses to niacin in Chinese patients with dyslipidemiaMiao Hu, Ya-Ling Yang, Chi-Fai Ng, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 18, 2010
High index of microcirculatory resistance level after successful primary percutaneous coronary intervention can be improved by intracoronary administration of nicorandilNoritoshi Ito, Shinsuke Nanto, Yasuji Doi, et al.
Journal of Molecular and Cellular Cardiology|December 24, 2019
Progranulin deficiency leads to enhanced age-related cardiac hypertrophy through complement C1q-induced β-catenin activationYinghong Zhu, Tohru Ohama, Ryota Kawase, et al.
Journal of Atherosclerosis and Thrombosis|March 22, 2017
Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting StateTakashi Miida, Kunihiro Nishimura, Satoshi Hirayama, et al.
Journal of Atherosclerosis and Thrombosis|October 8, 2020
Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density LipoproteinTakeshi Okada, Mizuki Sumida, Tohru Ohama, et al.
Pageof 9